Avenue Therapeutics Stock Quote ATXI - Stock Price, News, Charts, Message Board, Trades

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Avenue Therapeutics Inc (ATXI) Quote

Avenue Therapeutics Inc (ATXI)

1.81

-0.13

( -6.70% )

Updated: 11:58:39

Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Current Price

1.81

Bid

1.81

Ask

1.88

Volume

12,617

1.81 Day's Range 1.96

1.60 52 Week Range 26.4675

Market Cap

Previous Close

1.94

Open

1.95

Last Trade

Last Trade Time

11:52:25

Financial Volume

$ 23,687

VWAP

1.8774

Average Volume (3m)

45,333

Shares Outstanding

1,431,356

Dividend Yield

-

PE Ratio

-0.26

Earnings Per Share (EPS)

-7.25

Revenue

-

Net Profit

-10.38M

Avenue Therapeutics Inc is a specialty pharmaceutical company that develops and markets pharmaceutical products for the acute care setting. It focuses on developing its product candidate, an intravenous (IV) formulation of tramadol HCI (IV Tramadol), for post-operative acute pain. Avenue Therapeutics Inc is a specialty pharmaceutical company that develops and markets pharmaceutical products for the acute care setting. It focuses on developing its product candidate, an intravenous (IV) formulation of tramadol HCI (IV Tramadol), for post-operative acute pain.

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.avenuetx.com

Headquarters

Dover, Delaware, USA

Founded

-

Avenue Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ATXI. The last closing price for Avenue Therapeutics was $1.94. Over the last year, Avenue Therapeutics shares have traded in a share price range of $ 1.60 to $ 26.4675.

Avenue Therapeutics currently has 1,431,356 shares outstanding. The market capitalization of Avenue Therapeutics is $2.78 million. Avenue Therapeutics has a price to earnings ratio (PE ratio) of -0.26.

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Avenue Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights

MIAMI, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization...

Avenue Therapeutics to Participate in Maxim Group’s 2024 Healthcare Virtual Summit

MIAMI, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization...

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.3001	-14.2220747832	2.1101	2.15	1.79	36154	1.9893769	CS
4	-0.45	-19.9115044248	2.26	2.4083	1.6	29875	2.01270023	CS
12	-1.215	-40.1652892562	3.025	3.1	1.6	45333	2.1639696	CS
26	-1.54	-45.9701492537	3.35	3.9787	1.6	45107	2.6497887	CS
52	-12.44	-87.298245614	14.25	26.4675	1.6	1592786	17.96002411	CS
156	-1404.44	-99.8712888889	1406.25	1530	1.6	1774127	320.20144768	CS
260	-6725.69	-99.9730955035	6727.5	14130	1.6	1146886	710.10359841	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
CTNTCheetah Net Supply Chain Service Inc	$ 5.07 (171.12%)	100.77M
ZJKZJK Industrial Company Ltd	$ 14.40 (127.13%)	14.18M
CTORCitius Oncology Inc	$ 1.65 (61.76%)	92.34M
JANXJanux Therapeutics Inc	$ 62.965 (56.71%)	4.5M
GWAVGreenwave Technology Solutions Inc	$ 0.5676 (55.51%)	291.95M
REVBRevelation Biosciences Inc	$ 0.5376 (-43.40%)	2.7M
OMEXOdyssey Marine Exploration Inc	$ 0.47415 (-36.37%)	2.9M
GELSGelteq Ltd	$ 2.6001 (-31.94%)	201.07k
STSSSharps Technology Inc	$ 2.35 (-29.93%)	174.55k
SNTISenti Biosciences Inc	$ 7.08 (-29.20%)	5.38M
GWAVGreenwave Technology Solutions Inc	$ 0.5675 (55.48%)	291.95M
SMCISuper Micro Computer Inc	$ 41.1873 (-1.94%)	146.15M
CTNTCheetah Net Supply Chain Service Inc	$ 5.07 (171.12%)	100.77M
CHRSCoherus BioSciences Inc	$ 1.98 (44.53%)	94.56M
CTORCitius Oncology Inc	$ 1.65 (61.76%)	92.34M

tw0122

tw0122 1 month ago

ATXI 2.40 + 18% up to 2.80s earlier higher risk about 1m float
2.24-2.34 need support to hold and some follow through
2.51- 3.02 profit zone 1
3.38- 3.81 profit zone 2

Monksdream

Monksdream 4 months ago

ATXI new 52 week low

Disquisition

Disquisition 7 months ago

INCOMPREHENSIBLE DUMPING

jelaco

jelaco 9 months ago

When is the Nas min compliance hearing.. anyone hear anything on that? Also, when's the r/s coming?

Animas

Animas 10 months ago

yea I flipped twice and loss twice.

DeafTrader2

DeafTrader2 10 months ago

I flipped it . No longer holding this ticker .

Animas

Animas 10 months ago

Notice of Effectiveness: New Five Year Low .113
R/S Coming Soon, to Stay Alive.

heyitsmeagain

heyitsmeagain 10 months ago

81vette

81vette 10 months ago

Todays email to me from ATXI,approved increase of outstanding to 200m(from 75m) also warrants issued .30(also reduced previous to exercise at .30)reason was they only had 161k cash left(ran out of $) debt is now $191m

glenn1919

glenn1919 10 months ago

ATXI..............................................https://stockcharts.com/h-sc/ui?s=ATXI&p=W&b=5&g=0&id=p86431144783

DeafTrader2

DeafTrader2 10 months ago

Chart is improving ... Have bottomed out ..

YUUUPPPP

DeafTrader2

DeafTrader2 10 months ago

Wow ! ... What Happened Back Then ? Curious

DeafTrader2

DeafTrader2 10 months ago

IV Tramadol itself is a huge profit but are there other competitors that sell this drug ?

DeafTrader2

DeafTrader2 10 months ago

Is this stock a good buy right now ? 200M o/s

81vette

81vette 11 months ago

Filing states,approved raising o/s to 200M from 75M

81vette

81vette 11 months ago

I lost on first try to play,waiting for a bullish sign to try again (maybe,lose more) volume fading out is bad also

81vette

81vette 11 months ago

Buyout is best for shareholders short term with a big run and done

👍️ 1 💯 1 ☝️ 1

DeafTrader2

DeafTrader2 11 months ago

Is buy out a good thing for this ticker ?

DeafTrader2

DeafTrader2 11 months ago

Bottomed Out ... Shoulda, coulda, woulda ..... ?

RAlbert

RAlbert 11 months ago

Why so? What am I missing here?

DeafTrader2

DeafTrader2 11 months ago

Pendant northward ... sqeeze as FK

DeafTrader2

DeafTrader2 11 months ago

I am pissed that I FLIPPED THIS Today .l.. STUPID

81vette

81vette 11 months ago

Money raise warrants,ends tomorrow,ppl loading up,accumulation continues

🏁 1 👍️ 1 💯 1 ☝️ 1

DeafTrader2

DeafTrader2 11 months ago

this plane crashing back to this level ...

TheFinalCD

TheFinalCD 11 months ago

atxi .18's

get em while they're hot

LOL

Sunset Kid

Sunset Kid 11 months ago

Current O/S is 30M per dilution tracker. 90% were sold to investors in Nov and Jan. @ .30/share. Those transactions have provided $10M to the company for 2024 operating budget. https://dilutiontracker.com/app/search/ATXI

Sunset Kid

Sunset Kid 11 months ago

They sold 16.5 million shares (warrants) @ .30 for $5M. Funding for 2024 in place with less than 20M outstanding. This surge means something good is coming, imo. This is on everyones radar now. Let's squeeze the shorts to over a buck this week.

Sunset Kid

Sunset Kid 11 months ago

ATXI is #1 weekly and monthly gainer under a buck. Float has traded multipble times last week. Lets rock their world.

glenn1919

glenn1919 11 months ago

ATXI...........................................https://stockcharts.com/h-sc/ui?s=ATXI&p=W&b=5&g=0&id=p86431144783

Sauerkraut

Sauerkraut 11 months ago

Yes. Worked out well. Now sell @.30 and stopp @.15.
Glty

TheFinalCD

TheFinalCD 11 months ago

correction .1981 avg

im tired

good weekend all

TheFinalCD

TheFinalCD 11 months ago

good call I had 20k bid @ .1625 it stops .1632 :/

MFalgoz

I bought 10k @ .2216 & 10K .175

holding 20k avg .2081

wonder if it tests .15 again?

may wait to see before I add more

38 to 18 what a shitshow

RAlbert

RAlbert 11 months ago

The warrants exercising at little over 30 cents is a good sign when compared with current share price. It is a steal to buy in at .185

DeafTrader2

DeafTrader2 11 months ago

Will add position Monday and Tuesday

81vette

81vette 11 months ago

Tripled my position with .185s,run started 17ish yesterday

👍️ 1 💯 1 ☝️ 1

DeafTrader2

DeafTrader2 11 months ago

Its a F.U. message from CEO ... !!!

DeafTrader2

DeafTrader2 11 months ago

Avenue Therapeutics Shares Drop 42% After Warrants Exercised

81vette

81vette 11 months ago

Ppl saying dilution,it’s warrants 20-50k orders,could run out (15m issued) before 9th (I wanted to say soon,but that’s just the greed/devil on my shoulder lol)

81vette

81vette 11 months ago

Pr states “could be strategic partnership” bring on a big name pharma and that 1.55 will be pffft (could be why only raising 5m,make partner pay the 50m for study and phase 4-5 to market,or sell it for 300m,lots of speculation on many ppls minds,confidence to me would be insider’s buying,that might create big run up to the 1.55

trendzone

trendzone 11 months ago

Not in the stock price,but if someone keeps averaging down from much higher levels too many times,and the stock keeps tanking, they could find themselves in a situation of being down that much on the amount of money they originally invested.

TheFinalCD

TheFinalCD 11 months ago

at least we are doing better than IVP

what a falling knife that was

81vette

81vette 11 months ago

$1.55 issued exercise,reduced price is .3006,closing on 9th

TheFinalCD

TheFinalCD 11 months ago

VWAP .2317

todays news didnt help https://www.globenewswire.com/news-release/2024/01/05/2804696/0/en/Avenue-Therapeutics-Enters-into-Warrant-Exercise-Transactions-for-5-0-Million-in-Proceeds.html

Triple nickle

Triple nickle 11 months ago

Yup in it avg’ing down thought it would go .18 but not happening

Sauerkraut

Sauerkraut 11 months ago

TheFinalCD

TheFinalCD 11 months ago

how is anything down more than -100%

please tell us LL

Message in reply to:
If you were compared to a stock, you would be considered a toxic diluted OTC that's down over 300% from its highs.

Sauerkraut

Sauerkraut 11 months ago

Closing the Gap

TheFinalCD

TheFinalCD 11 months ago

where you at with atxi

you still in, cut bait, coming back??

trickle nickle @ .48 https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173562791

Message in reply to:
I tap it to keep it moving but to answer your question worst .28 I don’t think we’re done just yet this is the first day of three

TheFinalCD

TheFinalCD 11 months ago

sure just do the same when you see me on a board but not posting

Message in reply to:
I missed it,was busy with other things,thanks for the heads up,appreciated !!

TheFinalCD

TheFinalCD 11 months ago

filled more .21's will it hold???

Avenue Therapeutics

Reserve Bank of NZ Offic...

Btp Tf 3,25% St46 Eur

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions